Largest biotech by total liabilities

Everything the company owes, as its balance sheet stood at the end of the latest fiscal year.

Amgen leads the 24 biotech ranked by total liabilities, at NZ$149B, ahead of Gilead Sciences (NZ$66.2B) and Biogen (NZ$20.3B). Figures as of 18 Nov 2026, 14:51 UTC, from Yahoo Finance quotes.

Key facts

Companies ranked
24
First
AmgenNZ$149B
Median
NZ$1.3B
Combined market value
NZ$1.53T
Countries
5

Market values as of .

Largest biotech by total liabilities
#CompanyTotal liabilities ↓Market capPriceToday1 yearPrice, 30 daysCountry
1AmgenAMGN · Health CareNZ$149BNZ$442.3BNZ$817.65 1.85% down 34% up United States
2Gilead SciencesGILD · Health CareNZ$66.2BNZ$381.6BNZ$307.63 0.68% down 33% up United States
3BiogenBIIB · Health CareNZ$20.3BNZ$67.4BNZ$455.78 0.10% down 49% up United States
4ModernaMRNA · Health CareNZ$6.7BNZ$149.1BNZ$368.38 2.08% down 755% up United States
5BioNTechBNTX · Health CareNZ$5.6BNZ$38.2BNZ$154.06 0.20% down 16% down Germany
6QiagenQGEN · Health CareNZ$4.6BNZ$18.7BNZ$90.38 0.13% down 12% up Netherlands
7Halozyme TherapeuticsHALO · Health CareNZ$4.5BNZ$19.9BNZ$174.35 0.13% down 37% up United States
8Neurocrine BiosciencesNBIX · Health CareNZ$2.5BNZ$30.3BNZ$299.64 0.72% down 20% up United States
9argenxARGX · Health CareNZ$2.5BNZ$109.6BNZ$1,742.15 1.07% up 4% up Belgium
10ImmunityBioIBRX · Health CareNZ$1.8BNZ$11.9BNZ$11.19 1.76% down 193% up United States
11RepligenRGEN · Health CareNZ$1.5BNZ$19.8BNZ$309.77 5.00% up 5% up United States
12Revolution MedicinesRVMD · Health CareNZ$1.3BNZ$62.4BNZ$288.50 2.52% down 131% up United States
13ExelixisEXEL · Health CareNZ$1.2BNZ$30.4BNZ$124.72 0.09% up 63% up United States
14Bio-TechneTECH · Health CareNZ$870.4MNZ$20.8BNZ$132.30 0.14% up 26% up United States
15CRISPR TherapeuticsCRSP · Health CareNZ$624.7MNZ$7.3BNZ$75.27 3.06% up 21% down Switzerland
16VaxcytePCVX · Health CareNZ$577MNZ$16.9BNZ$106.87 1.09% down 22% up United States
17Adaptive BiotechnologiesADPT · Health CareNZ$523.4MNZ$8.4BNZ$51.64 0.35% down 88% up United States
18Kodiak SciencesKOD · Health CareNZ$353.2MNZ$11.5BNZ$175.36 0.41% down 396% up United States
19Twist BioscienceTWST · Health CareNZ$307.3MNZ$14.1BNZ$206.18 1.20% up 340% up United States
20Kymera TherapeuticsKYMR · Health CareNZ$296.8MNZ$18.9BNZ$221.60 0.25% up 87% up United States
21Scholar Rock HoldingSRRK · Health CareNZ$288.8MNZ$10.4BNZ$85.63 4.43% up 14% up United States
22Krystal BiotechKRYS · Health CareNZ$207.8MNZ$16.3BNZ$551.34 1.52% up 46% up United States
23ImmunovantIMVT · Health CareNZ$190MNZ$12.5BNZ$60.64 0.38% up 43% up United States
24CG OncologyCGON · Health CareNZ$70.9MNZ$12.7BNZ$141.99 1.12% down 85% up United States

Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.

Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Total liabilities is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Where a company reports no total-liabilities line, it is worked out as assets less equity. Sums are converted from US dollars at today's exchange rate (1 USD = 1.8191 NZD).

Questions and answers

Which biotech rank first by total liabilities?

Amgen (NZ$149B), Gilead Sciences (NZ$66.2B) and Biogen (NZ$20.3B) are the top three of the 24 biotech ranked by total liabilities as of 18 Nov 2026, 14:51 UTC.

How many biotech are in this ranking?

24 are ranked by total liabilities.

What are these biotech worth together?

The 24 biotech ranked by total liabilities have a combined market value of NZ$1.53T as of 18 Nov 2026, 14:51 UTC.

What does ranking by total liabilities measure?

Everything the company owes, as its balance sheet stood at the end of the latest fiscal year.

Cite this page

Funkfolio, “Largest biotech by total liabilities”, data as of 18 November 2026. https://funkfolio.com/companies/category/biotech?by=total-liabilities

Underlying data: Yahoo Finance; SEC EDGAR.